Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases

Eur J Cancer. 2018 Mar:91:177-179. doi: 10.1016/j.ejca.2017.11.031. Epub 2018 Jan 16.

Authors

Roberta Giuffrida¹, Karl Kashofer², Emi Dika³, Annalisa Patrizi³, Carlotta Baraldi³, Nicola Di Meo⁴, Iris Zalaudek⁵

Affiliations

¹ Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Italy.
² Institute of Pathology, Medical University of Graz, Austria.
³ Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
⁴ Dermatology Clinic, Hospital Maggiore, University of Trieste, Italy.
⁵ Dermatology Clinic, Hospital Maggiore, University of Trieste, Italy. Electronic address: iris.zalaudek@gmail.com.

PMID: 29373258
DOI: 10.1016/j.ejca.2017.11.031

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Anilides / adverse effects*
Antineoplastic Agents / adverse effects*
Carcinoma, Basal Cell / drug therapy*
Carcinoma, Basal Cell / pathology
Cell Proliferation / drug effects*
Fatal Outcome
Female
Humans
Male
Melanoma / chemically induced*
Melanoma / secondary
Melanoma / surgery
Pyridines / adverse effects*
Risk Factors
Skin Neoplasms / chemically induced*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Skin Neoplasms / surgery
Time Factors
Treatment Outcome
Tumor Burden / drug effects

Substances

Anilides
Antineoplastic Agents
HhAntag691
Pyridines